MiMARK Diagnostics — Grant · €1.5M

MiMARK, a spin-off from Vall d'Hebron developing in vitro diagnostics for endometrial cancer, won €1.5M through EIT Health's Wild Card programme. This is programme funding rather than a priced venture round.

LeadEIT Health RoundGrant Announced2 Feb 2021Not counted in totals CityBarcelona SectorDiagnostics / women's healthSource F

Something wrong? Suggest a correction →